Posts Tagged ‘Altabax’

Almirall has acquired the rights to Veltin® and Altabax® from Stiefel, a GSK company, in exchange for its distribution rights to Toctino®

The addition of these two products will significantly enhance Almirall’s Dermatology business, and contribute to Almirall’s vision to become a leading player in Dermatology. Veltin® and Altabax® will be commercialised through Aqua Pharmaceuticals, Almirall’s US affiliate. Both medicines are a perfect fit with our current portfolio, are aligned with our global strategy and strengthen our […]